查找临床试验
已按「骨髓纤维化」检索，对应国际通用词 myelofibrosis
共找到 12 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 11:24，每 5 分钟自动同步Haplo-HSCT for Myelofibrosis
China
年龄 不限 – 不限
Peking University People's Hospital
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
United States、Belgium、Bulgaria、Canada、Czechia 等 12 国
年龄 18 Years – 不限
Karyopharm Therapeutics Inc
68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy Evaluation of Myelofibrosis.
China
年龄 18 Years – 不限
The First Affiliated Hospital of Xiamen University
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
United States、Argentina、Australia、China、India 等 12 国
年龄 18 Years – 不限
Novartis Pharmaceuticals
18F-FAPI PET/MRI Imaging in Myelofibrosis: a Prospective Observational Study.
China
年龄 18 Years – 80 Years
First Affiliated Hospital of Zhejiang University
Asian Myeloproliferative Neoplasm (MPN) Registry
Hong Kong
年龄 18 Years – 不限
The University of Hong Kong
A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis
China
年龄 18 Years – 80 Years
Chengdu Zenitar Biomedical Technology Co., Ltd
Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis
Hong Kong
年龄 18 Years – 不限
The University of Hong Kong
A Study of GLB-001 in Patients With Myeloid Malignancies
China
年龄 18 Years – 不限
Hangzhou GluBio Pharmaceutical Co., Ltd.
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
China
年龄 18 Years – 不限
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
United States、Argentina、Australia、Austria、Belgium 等 12 国
年龄 18 Years – 不限
Takeda
Evaluating Safety ,Tolerability, Pharmacokinetic,Efficacy of WJ01024 or WJ01024 Combined With Ruxolitinib in Patients With Myelofibrosis
China
年龄 18 Days – 不限
Henan Cancer Hospital